February 27, 2022 BennuBio announced it received the Society for Laboratory Automation and Screening (SLAS) prestigious Ignite award at SLAS’s annual International Conference and Exhibition in Boston, MA on February 9, 2022. The SLAS Ignite Award recognizes the best start-up or emerging company exhibiting within Innovation AveNEW, a specially designated area for start-ups and emerging […]
BennuBio has hired Matthew Hess as Chief Operations Officer. He has over 20 years experience helping start-up companies bring technology to market. With a background in software engineering and experience in life sciences tools and flow cytometry, he was instrumental in the success of Intellicyt, a local company, which pioneered the concept of high-throughput flow
In response to continuing success of their novel large particle flow cytometer, BennuBio has moved to a larger facility to consolidate engineering, administrative and laboratory in one building. Formerly located in the WESST Enterprise Center, and with shared laboratory space at TriCore Reference Laboratories, BennuBio is now located at 6610 Gulton Ct. NE in Albuquerque.
BY KEVIN ROBINSON-AVILA / JOURNAL STAFF WRITER PUBLISHED: FRIDAY, JULY 17TH, 2020 Medical device startup BennuBio Inc. won a $1 million National Institutes of Health grant to add rapid analysis capability for complex, three-dimensional cellular “spheroids” to its existing cell-screening technology. BennuBio already developed a super-fast cytometer, or cell meter, that can process single-cell samples 100
BennuBio was awarded an NIH (National Institute of Health) SBIR (Small Business Innovation Research) grant that will advance the Company’s development of a novel analytic tool for 3D tissue models. Mimicking natural cellular activities, 3D tissue models—called spheroids—play an increasingly critical role in cancer research and drug screening and reduce the need for animals in
NEW YORK – Flow cytometry startup BennuBio has closed on $5 million of a $7 million Series B financing round, which it plans to use to expand commercial efforts, accelerate development of new features for its initial product, and develop additional complementary products. The funding round was led by new investor Co-Win Ventures, with additional